Indium In 111 pentetreotide

N/A

Report date: 2025/11/19 17:58:29
NME

Base Information

Drug NameIndium In 111 pentetreotide
Drug Alias Name铟[111In]-喷曲肽111In-pentetreotide铟[111In] 喷曲肽DTPA-octreotide-[111In]Pentetreotide-[111In] +[17
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Indium > 111In +[5
Mechanisms of ActionSingle-photon emission-computed tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsUveal melanomaDiagnostic agentsSkin Melanoma +[15
Global Approved IndicationsDiagnostic agentsNeuroendocrine Tumors
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCzechia
Original Approved Date1994/02/01
Country/TerritoryCzechiaUnited StatesSwitzerland
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesCurium Us Llc
Active IndicationsDiagnostic agentsNeuroendocrine Tumors
Inactive IndicationsUveal melanomaSkin MelanomaCNS Embryonal Tumor +[13

Other Information

ATC CodeV09IB01
Related LinksDrugBank